Keeping Track: Recent NDA Submissions Range From Acute Agitation To Von Hippel-Lindau Disease

 
• By Bridget Silverman
This edition of Keeping Track features nothing but NDAs

More from US FDA Performance Tracker

More from Regulatory Trackers